T

Translate Bio, A Sanofi Company

97 employees

Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Cystic Fibrosis
Rare Diseases
mRNA
Vaccines
mRNA therapeutics
messenger RNA
Therapeutics
Genetics
Infectious Diseases
Medical
Pulmonary Diseases

Date founded

2011

Funding rounds raised

Total raised

$64M

from 17 investors over 17 rounds

T

Translate Bio, A Sanofi Company raised $42M on December 1, 2017

Investors: Omega Funds and The Baupost Group

T

Translate Bio, A Sanofi Company raised $51M on January 10, 2017

Investors: Omega Funds, S.R. One Ltd, Atlas Venture and The Baupost Group

T

Translate Bio, A Sanofi Company raised $64M on July 30, 2015

Investors: Omega Funds, Leerink Partners LLC, Research Division, S.R. One Ltd, The Baupost Group, M Ventures and Partners HealthCare

T

Translate Bio, A Sanofi Company raised $21M on January 18, 2012

Investors: Omega Funds, M Ventures, S.R. One Ltd, Atlas Venture and Partners HealthCare

FAQ